| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |